# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY ONLY

I Background Information:

# B Applicant

Shenzhen Bioeasy Biotechnology Co., Ltd.

# C Proprietary and Established Names

BIOEASY™ U-Catch MAX Multi-Drug Test Cup, BIOEASY™ U-Catch MAX Multi-Drug Test Cup Rx

# D Regulatory Information

<table><tr><td colspan="1" rowspan="1">ProductCode(s)</td><td colspan="1" rowspan="1">Classification</td><td colspan="1" rowspan="1">RegulationSection</td><td colspan="1" rowspan="1">Panel</td></tr><tr><td colspan="1" rowspan="1">NFT</td><td colspan="1" rowspan="1">Class II</td><td colspan="1" rowspan="1">21 CFR 862.3100 -Amphetamine TestSystem</td><td colspan="1" rowspan="1">TX - ClinicalToxicology</td></tr><tr><td colspan="1" rowspan="1">NFW</td><td colspan="1" rowspan="1">Class I</td><td colspan="1" rowspan="1">21 CFR 862.3870 -Cannabinoid testsystem</td><td colspan="1" rowspan="1">TX - ClinicalToxicology</td></tr><tr><td colspan="1" rowspan="1">NFY</td><td colspan="1" rowspan="1">Class I</td><td colspan="1" rowspan="1">21 CFR 862.3250 -Cocaine and cocainemetabolite test system</td><td colspan="1" rowspan="1">TX - ClinicalToxicology</td></tr><tr><td colspan="1" rowspan="1">NGG</td><td colspan="1" rowspan="1">Class I</td><td colspan="1" rowspan="1">21 CFR 862.3610 -Methamphetaminetest system</td><td colspan="1" rowspan="1">TX - ClinicalToxicology</td></tr><tr><td colspan="1" rowspan="1">NGL</td><td colspan="1" rowspan="1">Class II</td><td colspan="1" rowspan="1">21 CFR 862.3650 -Opiate test system</td><td colspan="1" rowspan="1">TX - ClinicalToxicology</td></tr><tr><td colspan="1" rowspan="1">NFV</td><td colspan="1" rowspan="1">Class II</td><td colspan="1" rowspan="1">21 CFR 862.3170 -Benzodiazepine testsystem</td><td colspan="1" rowspan="1">TX - ClinicalToxicology</td></tr><tr><td colspan="1" rowspan="1">PTG</td><td colspan="1" rowspan="1">Class II</td><td colspan="1" rowspan="1">21 CFR 862.3620 -Methadone testsystem</td><td colspan="1" rowspan="1">TX - ClinicalToxicology</td></tr><tr><td colspan="1" rowspan="1">PTH</td><td colspan="1" rowspan="1">Class II</td><td colspan="1" rowspan="1">21 CFR 862.3150 -Barbiturate testsystem</td><td colspan="1" rowspan="1">TX - ClinicalToxicology</td></tr><tr><td colspan="1" rowspan="1">NGM</td><td colspan="1" rowspan="1">Unclassified</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">QAW</td><td colspan="1" rowspan="1">Class II</td><td colspan="1" rowspan="1">21 CFR 862.3910 -Tricyclicantidepressant drugstest system</td><td colspan="1" rowspan="1">TX - ClinicalToxicology</td></tr><tr><td colspan="1" rowspan="1">QBF</td><td colspan="1" rowspan="1">Class II</td><td colspan="1" rowspan="1">21 CFR 862.3700 -Propoxyphene testsystem</td><td colspan="1" rowspan="1">TX - ClinicalToxicology</td></tr><tr><td colspan="1" rowspan="1">DJG</td><td colspan="1" rowspan="1">Class II</td><td colspan="1" rowspan="1">21 CFR 862.3650 -Opiate test system</td><td colspan="1" rowspan="1">TX - ClinicalToxicology</td></tr></table>

# II Submission/Device Overview:

# A Purpose for Submission:

Modification of a previously cleared device (K182530) to add Amphetamine $( 5 0 0 ~ \mathrm { n g / m L }$ cutoff), Methamphetamine $( 5 0 0 ~ \mathrm { n g / m L }$ cutoff), Cocaine ( $1 5 0 ~ \mathrm { n g / m L }$ cutoff), EDDP $( 3 0 0 ~ \mathrm { n g / m L }$ cutoff), and 6-Acetylmorphine ( $1 0 ~ \mathrm { { n g / m L } }$ cutoff).

# B Measurand:

Amphetamine, Buprenorphine, Secobarbital, Oxazepam, Cocaine, 2- ethylidene-1,5- dimethyl-3,3-diphenylpyrrolidine, Methamphetamine, Methylenedioxymethamphetamine, Morphine, Methadone, Oxycodone, Phencyclidine, d-Propoxyphene, Nortriptyline, Cannabinoids and 6-Acetylmorphine

# C Type of Test:

Qualitative lateral flow immunochromatographic assay

# III Intended Use/Indications for Use:

A Intended Use(s): See Indications for Use below.

B Indication(s) for Use: BIOEASY™ U-Catch MAX Multi-Drug Test Cup tests are competitive binding, lateral flow immunochromatographic assays for qualitative and simultaneous detection of Amphetamine,

Buprenorphine, Secobarbital, Oxazepam, Cocaine, 2- ethylidene-1,5-dimethyl-3,3- diphenylpyrrolidine, Methamphetamine, Methylenedioxymethamphetamine, Morphine, Methadone, Oxycodone, Phencyclidine, d-Propoxyphene, Nortriptyline and Marijuana in human urine at the cutoff concentrations of:

Drug(Identifier)

Cut-off level

Amphetamine (AMP) 500 ng/mL Buprenorphine (BUP) 10 ng/mL Secobarbital (BAR) 300 ng/mL Oxazepam (BZO) 300 ng/mL Cocaine (COC) 150 ng/mL 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) 300 ng/mL Methamphetamine (MET) 500 ng/mL Methylenedioxymethamphetamine (MDMA) 500 ng/mL Morphine (MOP 300) 300 ng/mL Methadone (MTD) 300 ng/mL Oxycodone (OXY) 100 ng/mL Phencyclidine (PCP) 25 ng/mL d-Propoxyphene (PPX) 300 ng/mL Nortriptyline (TCA) 1000 ng/mL Marijuana (THC) 50 ng/mL

BIOEASY™ U-Catch MAX Multi-Drug Test Cup offers any combinations of the above listed analytes. It is for in vitro diagnostic use only. It is intended for OTC use.

The tests may yield positive results for the prescription drugs Buprenorphine, Nortriptyline, Oxazepam, Secobarbital, d-Propoxyphene, and Oxycodone when taken at or above prescribed doses. It is not intended to distinguish between prescription use or abuse of these drugs. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly in evaluating a preliminary positive result.

The tests provide only preliminary results. To obtain a confirmed analytical result, a more specific alternate chemical method must be used. GC/MS or LC/MS is the recommended confirmatory method.

BIOEASY™ U-Catch MAX Multi-Drug Test Cup Rx tests are competitive binding, lateral flow immunochromatographic assays for qualitative and simultaneous detection of Amphetamine, Buprenorphine, Secobarbital, Oxazepam, Cocaine, 2- ethylidene-1,5-dimethyl-3,3- diphenylpyrrolidine, Methamphetamine, Methylenedioxymethamphetamine, Morphine, Methadone, Oxycodone, Phencyclidine, d-Propoxyphene, Nortriptyline, Cannabinoids and 6- Acetylmorphine in human urine at the cutoff concentrations of:

Drug(Identifier)

Cut-off level

Amphetamine (AMP) Buprenorphine (BUP) Secobarbital (BAR) Oxazepam (BZO)

500 ng/mL   
10 ng/mL   
300 ng/mL   
300 ng/mL

Cocaine (COC) 150 ng/mL 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) 300 ng/mL Methamphetamine (MET) 500 ng/mL Methylenedioxymethamphetamine (MDMA) 500 ng/mL Morphine (MOP 300) 300 ng/mL Methadone (MTD) 300 ng/mL Oxycodone (OXY) 100 ng/mL Phencyclidine (PCP) 25 ng/mL d-Propoxyphene (PPX) 300 ng/mL Nortriptyline (TCA) 1000 ng/mL Cannabinoids (THC) 50 ng/mL 6-Acetylmorphine 10 ng/mL

BIOEASY™ U-Catch MAX Multi-Drug Test Cup Rx offers any combinations of the above listed analytes. It is for in vitro diagnostic use only. It is intended for prescription use.

The tests may yield positive results for the prescription drugs Buprenorphine, Nortriptyline, Oxazepam, Secobarbital, d-Propoxyphene, and Oxycodone when taken at or above prescribed doses. It is not intended to distinguish between prescription use or abuse of these drugs. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly in evaluating a preliminary positive result.

The tests provide only preliminary results. To obtain a confirmed analytical result, a more specific alternate chemical method must be used. GC/MS or LC/MS is the recommended confirmatory method.

C Special Conditions for Use Statement(s): Rx and OTC   
D Special Instrument Requirements: Not applicable

# IV Device/System Characteristics:

# A Device Description:

The BIOEASY™ U-Catch MAX Multi-Drug Test Cup and the BIOEASY™ U-Catch MAX Multi-Drug Test Cup Rx are immunochromatographic assays that use a lateral flow system for the qualitative detection of target drugs and drug metabolites in human urine. The products are single-use in vitro diagnostic devices. The candidate device contains a Cup device, a package insert and a urine cup for sample collection. Each test device is sealed with a desiccant in an aluminum pouch.

The BIOEASY™ U-Catch MAX Multi-Drug Test Cup (OTC use) detects all analytes listed above except 6-Acetylmorphine.

The BIOEASY™ U-Catch MAX Multi-Drug Test Cup Rx (Prescription Use) detects all analytes listed above.

# B Principle of Operation:

The candidate devices are rapid tests for the qualitative detection of target drugs and drug metabolites in urine samples. The tests are lateral flow chromatographic immunoassays. During testing, a urine specimen migrates upward by capillary action. If target drugs present in the urine specimen are below the cutoff concentration, it will not saturate the binding sites of its specific monoclonal mouse antibody coated on the particles. The antibody-coated particles will then be captured by immobilized drug-conjugate and a visible colored line will show up in the test line region. The colored line will not form in the test line region if the target drug level exceeds its cutoff concentration because it will saturate all the binding sites of the antibody coated on the particles. A band should form in the control region of the devices regardless of the presence of drug or metabolite in the sample to indicate that the tests have been performed properly.

# V Substantial Equivalence Information:

A Predicate Device Name(s): AssureTech DOA Dipstick Screen Panel Tests, AssureTech DOA Integrated Cup Tests   
B Predicate 510(k) Number(s): K201630

C Comparison with Predicate(s):

<table><tr><td colspan="1" rowspan="1">Device &amp; PredicateDevice(s):</td><td colspan="1" rowspan="1">K230238</td><td colspan="1" rowspan="1">K201630</td></tr><tr><td colspan="1" rowspan="1">Device Trade Name</td><td colspan="1" rowspan="1">BIOEASYTM U-CatchMAX Multi-Drug TestCup, BIOEASYTM U-Catch MAX Multi-DrugTest Cup Rx</td><td colspan="1" rowspan="1">AssureTech DOADipstick Screen PanelTests, AssureTechDOA Integrated CupTests</td></tr><tr><td colspan="1" rowspan="1">General DeviceCharacteristic Similarities</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Intended Use/IndicationsFor Use</td><td colspan="1" rowspan="1">For the qualitativedetermination of drugs-of-abuse in humanurine.</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Specimen</td><td colspan="1" rowspan="1">Human urine</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Methodology</td><td colspan="1" rowspan="1">Competitive binding,Lateral flow Immuno-chromatographic assaybased on the principle ofantigen antibody</td><td colspan="1" rowspan="1">Same</td></tr><tr><td>500 ng/ml</td><td>immunochemistry Amphetamine (AMP):</td><td></td></tr><tr><td>Cutoff</td><td>Oxazepam (BZO): 300 ng/ml Cocaine (COC): 150 ng/ml Methamphetamine (MET): 500 ng/ml Morphine (MOR): 300 ng/mL Oxycodone(OXY) : 100 ng/ml Secobarbital (BAR): 300 ng/ml Methadone (MTD): 300 ng/ml Buprenorphine (BUP): 10 ng/ml Methylenedioxymetham phetamine (MDMA): 500 ng/ml Phencyclidine (PCP): 25 ng/ml Nortriptyline (TCA): 1000 ng/ml 2-ethylidene-1,5- dimethyl-3,3- diphenylpyrrolidine</td><td>Same</td></tr><tr><td>General Device Characteristic Differences</td><td>(EDDP): 300 ng/ml d-Propoxyphene (PPX): 300 ng/ml</td><td></td></tr><tr><td>Intended users</td><td>Over the Counter (OTC) Use and Prescription Use</td><td>Prescription Use Only</td></tr><tr><td>Marijuana (11-Nor-∆9- Tetrahydrocannabinol-9- COOH) (THC)</td><td>50 ng/ml</td><td>20 ng/mL</td></tr></table>

# VI Standards/Guidance Documents Referenced:

None referenced.

# VII Performance Characteristics (if/when applicable):

# A Analytical Performance:

1. Precision/Reproducibility:

Precision studies were carried out for samples with concentrations of - $- 1 0 0 \%$ cutoff, - $7 5 \%$ cutoff, $- 5 0 \%$ cutoff, $- 2 5 \%$ cutoff, cutoff, $+ 2 5 \%$ cutoff, $+ 5 0 \%$ cutoff, $+ 7 5 \%$ cutoff and $+ 1 0 0 \%$ cutoff. These samples were prepared by spiking drug in negative urine samples. Each drug concentration was confirmed by LC/MS. All sample aliquots were tested in a blinded fashion. For each concentration, tests were performed in two runs per day for 25 days per device in a randomized order using 3 reagent lots. The results obtained are summarized in the following tables for Amphetamine 500, Cocaine 150, Methamphetamine 500, 2- ethylidene1, 5-dimethyl-3, 3-diphenylpyrrolidine (EDDP), and 6-acetylmorphine (6-AM). The data for Buprenorphine, Methylenedioxymethamphetamine, Secobarbital, Oxazepam, Morphine, Methadone, Oxycodone, Phencyclidine, d-Propoxyphene, Nortriptyline and Cannabinoids were previously reported in K182530.

<table><tr><td colspan="1" rowspan="3">Drug test</td><td colspan="2" rowspan="2">% of cutoff</td><td colspan="1" rowspan="1">Number of</td><td colspan="6" rowspan="1">Result</td></tr><tr><td colspan="1" rowspan="1">off</td><td colspan="1" rowspan="1">Determinations</td><td colspan="2" rowspan="1">Lot 1</td><td colspan="2" rowspan="1">Lot 2</td><td colspan="2" rowspan="1">Lot 3</td></tr><tr><td colspan="2" rowspan="1"></td><td colspan="1" rowspan="1">per lot</td><td colspan="1" rowspan="1">+</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">+</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">+</td><td colspan="1" rowspan="1">-</td></tr><tr><td colspan="1" rowspan="9">AMP 500</td><td colspan="2" rowspan="1">Negative</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="2" rowspan="1">-75% cutoff</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td></tr><tr><td colspan="2" rowspan="1">-50% cutoff</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td></tr><tr><td colspan="2" rowspan="1">-25% cutoff</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td></tr><tr><td colspan="2" rowspan="1">cutoff</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">28</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">24</td><td colspan="1" rowspan="1">26</td><td colspan="1" rowspan="1">24</td><td colspan="1" rowspan="1">26</td></tr><tr><td colspan="2" rowspan="1">+25% cutoff</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="2" rowspan="1">+50% cutoff</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="2" rowspan="1">+75% cutoff</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="2" rowspan="1">+100% cutoff</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="9">COC 150</td><td colspan="2" rowspan="1">Negative</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td></tr><tr><td colspan="2" rowspan="1">-75% cutoff</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td></tr><tr><td colspan="2" rowspan="1">-50% cutoff</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td></tr><tr><td colspan="2" rowspan="1">-25% cutoff</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td></tr><tr><td colspan="2" rowspan="1">cutoff</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">28</td><td colspan="1" rowspan="1">21</td><td colspan="1" rowspan="1">29</td><td colspan="1" rowspan="1">28</td><td colspan="1" rowspan="1">22</td></tr><tr><td colspan="2" rowspan="1">+25% cutoff</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="2" rowspan="1">+50% cutoff</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="2" rowspan="1">+75% cutoff</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="2" rowspan="1">+100% cutoff</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="9">MET 500</td><td colspan="2" rowspan="1">Negative</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td></tr><tr><td colspan="2" rowspan="1">-75%cutoff</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td></tr><tr><td colspan="2" rowspan="1">-50% cutoff</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td></tr><tr><td colspan="2" rowspan="1">-25% cutoff</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td></tr><tr><td colspan="2" rowspan="1">cutoff</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">27</td><td colspan="1" rowspan="1">27</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">25</td><td colspan="1" rowspan="1">25</td></tr><tr><td colspan="2" rowspan="1">+25% cutoff</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="2" rowspan="1">+50% cutoff</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="2" rowspan="1">+75% cutoff</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="2" rowspan="1">+100% cutoff</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="9">EDDP 300</td><td colspan="2" rowspan="1">Negative</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td></tr><tr><td colspan="2" rowspan="1">-75% cutoff</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td></tr><tr><td colspan="2" rowspan="1">-50% cutoff</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td></tr><tr><td colspan="2" rowspan="1">-25% cutoff</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td></tr><tr><td colspan="2" rowspan="1">cutoff</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">26</td><td colspan="1" rowspan="1">24</td><td colspan="1" rowspan="1">24</td><td colspan="1" rowspan="1">26</td><td colspan="1" rowspan="1">25</td><td colspan="1" rowspan="1">25</td></tr><tr><td colspan="2" rowspan="1">+25% cutoff</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="2" rowspan="1">+50% cutoff</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="2" rowspan="1">+75% cutoff</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="2" rowspan="1">+100% cutoff</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="5">6-AM 10</td><td colspan="2" rowspan="1">Negative</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td></tr><tr><td colspan="2" rowspan="1">-75% cutoff</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td></tr><tr><td colspan="2" rowspan="1">-50% cutoff</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td></tr><tr><td colspan="2" rowspan="1">-25% cutoff</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td></tr><tr><td colspan="2" rowspan="1">cutoff</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">24</td><td colspan="1" rowspan="1">26</td><td colspan="1" rowspan="1">26</td><td colspan="1" rowspan="1">24</td><td colspan="1" rowspan="1">27</td><td colspan="1" rowspan="1">23</td></tr><tr><td colspan="1" rowspan="7">Drug test</td><td colspan="1" rowspan="3">% of cutoff</td><td colspan="1" rowspan="3">Number ofDeterminationsper lot</td><td colspan="6" rowspan="1">Result</td></tr><tr><td colspan="2" rowspan="1">Lot 1</td><td colspan="2" rowspan="1">Lot 2</td><td colspan="2" rowspan="1">Lot 3</td></tr><tr><td colspan="1" rowspan="1">+</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">+</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">+</td><td colspan="1" rowspan="1">-</td></tr><tr><td colspan="1" rowspan="1">+25% cutoff</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">+50% cutoff</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">+75% cutoff</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">+100% cutoff</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0</td></tr></table>

2. Linearity:

Not Applicable.

3. Analytical Specificity/Interference:

# Cross-Reactivity:

To test cross-reactivity, drug metabolites and other structurally related compounds that are likely to cross-react in urine samples were spiked into negative urine and were tested using three lots of each device. The lowest concentration that caused a positive result for each compound is listed below for Amphetamine 500, Cocaine 150, Methamphetamine 500, 2- ethylidene-1, 5-dimethyl-3, 3-diphenylpyrrolidine (EDDP), and 6-acetylmorphine (6-AM). The data for Buprenorphine, Methylenedioxymethamphetamine, Secobarbital, Oxazepam, Morphine, Methadone, Oxycodone, Phencyclidine, d-Propoxyphene, Nortriptyline and Cannabinoids were reported in K182530.

<table><tr><td rowspan=1 colspan=1>AMP500(Cutoff=500 ng/mL)</td><td rowspan=1 colspan=1>ResultPositive at (ng/ml)</td><td rowspan=1 colspan=1>%Cross-Reactivity</td></tr><tr><td rowspan=1 colspan=1>D - Amphetamine</td><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>L - Amphetamine</td><td rowspan=1 colspan=1>10000</td><td rowspan=1 colspan=1>5%</td></tr><tr><td rowspan=1 colspan=1>DL - Amphetamine</td><td rowspan=1 colspan=1>1500</td><td rowspan=1 colspan=1>33%</td></tr><tr><td rowspan=1 colspan=1>Phentermine</td><td rowspan=1 colspan=1>15000</td><td rowspan=1 colspan=1>3.3%</td></tr><tr><td rowspan=1 colspan=1>Hydroxyamphetamine</td><td rowspan=1 colspan=1>4000</td><td rowspan=1 colspan=1>12.5%</td></tr><tr><td rowspan=1 colspan=1>Methylenedioxyamphetamine(MDA)</td><td rowspan=1 colspan=1>10000</td><td rowspan=1 colspan=1>5%</td></tr><tr><td rowspan=1 colspan=1>d-Methamphetamine</td><td rowspan=1 colspan=1>&gt; 100000</td><td rowspan=1 colspan=1>&lt;0.5%</td></tr><tr><td rowspan=1 colspan=1>1-Methamphetamine</td><td rowspan=1 colspan=1>&gt; 100000</td><td rowspan=1 colspan=1>&lt;0.5%</td></tr><tr><td rowspan=1 colspan=1>Ephedrine</td><td rowspan=1 colspan=1>&gt; 100000</td><td rowspan=1 colspan=1>&lt;0.5%</td></tr><tr><td rowspan=1 colspan=1>Methylenedioxyethylamphetamine</td><td rowspan=1 colspan=1>&gt; 100000</td><td rowspan=1 colspan=1>&lt;0.5%</td></tr><tr><td rowspan=1 colspan=1>3,4-methylenedioxymethamphetamine(MDMA)</td><td rowspan=1 colspan=1>&gt; 100000</td><td rowspan=1 colspan=1>&lt;0.5%</td></tr></table>

<table><tr><td colspan="1" rowspan="1">COC150(Cutoff=150 ng/mL)</td><td colspan="1" rowspan="1">ResultPositive at (ng/ml)</td><td colspan="1" rowspan="1">%Cross-Reactivity</td></tr><tr><td colspan="1" rowspan="1">Benzoylecgonine</td><td colspan="1" rowspan="1">150</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">Cocaine HCl</td><td colspan="1" rowspan="1">375</td><td colspan="1" rowspan="1">40%</td></tr><tr><td colspan="1" rowspan="1">Cocaethylene</td><td colspan="1" rowspan="1">6250</td><td colspan="1" rowspan="1">2.4%</td></tr><tr><td colspan="1" rowspan="1">Ecgonine</td><td colspan="1" rowspan="1">16000</td><td colspan="1" rowspan="1">0.9%</td></tr><tr><td colspan="1" rowspan="1">Norcocaine</td><td colspan="1" rowspan="1">50000</td><td colspan="1" rowspan="1">0.3%</td></tr></table>

<table><tr><td rowspan=1 colspan=1>MET500(Cutoff=500 ng/mL)</td><td rowspan=1 colspan=1>ResultPositive at (ng/ml)</td><td rowspan=1 colspan=1>%Cross-Reactivity</td></tr><tr><td rowspan=1 colspan=1>D(+)-Methamphetamine</td><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>(+/-)3,4-Methylenedioxy-n-ethylamphetamine (MDEA)</td><td rowspan=1 colspan=1>5000</td><td rowspan=1 colspan=1>10%</td></tr><tr><td rowspan=1 colspan=1>D/L-Methamphetamine</td><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>p-Hydroxymethamphetamine</td><td rowspan=1 colspan=1>5000</td><td rowspan=1 colspan=1>10%</td></tr><tr><td rowspan=1 colspan=1>D-Amphetamine</td><td rowspan=1 colspan=1>&gt; 100000</td><td rowspan=1 colspan=1>&lt;0.5%</td></tr><tr><td rowspan=1 colspan=1>L-Amphetamine</td><td rowspan=1 colspan=1>&gt;100000</td><td rowspan=1 colspan=1>&lt;0.5%</td></tr><tr><td rowspan=1 colspan=1>Chloroquine</td><td rowspan=1 colspan=1>25000</td><td rowspan=1 colspan=1>2%</td></tr><tr><td rowspan=1 colspan=1>(+/-)-Ephedrine</td><td rowspan=1 colspan=1>2000</td><td rowspan=1 colspan=1>25%</td></tr><tr><td rowspan=1 colspan=1>L-Methamphetamine</td><td rowspan=1 colspan=1>5000</td><td rowspan=1 colspan=1>10%</td></tr><tr><td rowspan=1 colspan=1>(+/-)3,4-Methylenedioxyamphetamine(MDA)</td><td rowspan=1 colspan=1>&gt; 100000</td><td rowspan=1 colspan=1>&lt;0.5%</td></tr><tr><td rowspan=1 colspan=1>β-Phenylethylamine</td><td rowspan=1 colspan=1>3750</td><td rowspan=1 colspan=1>13.3%</td></tr><tr><td rowspan=1 colspan=1>Trimethobenzamide</td><td rowspan=1 colspan=1>10000</td><td rowspan=1 colspan=1>5%</td></tr><tr><td rowspan=1 colspan=1>(+/-)3,4-Methylenedioxymethamphetamine(MDMA)</td><td rowspan=1 colspan=1>5000</td><td rowspan=1 colspan=1>10%</td></tr></table>

<table><tr><td rowspan=1 colspan=1>EDDP(Cutoff=300 ng/mL)</td><td rowspan=1 colspan=1>ResultPositive at (ng/ml)</td><td rowspan=1 colspan=1>% Cross-Reactivity</td></tr><tr><td rowspan=1 colspan=1>EDDP</td><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>Methadone</td><td rowspan=1 colspan=1>300000</td><td rowspan=1 colspan=1>0.1%</td></tr><tr><td rowspan=1 colspan=1>Doxylamine</td><td rowspan=1 colspan=1>&gt;100000</td><td rowspan=1 colspan=1>&lt;0.3%</td></tr><tr><td rowspan=1 colspan=1>LAAM HC1</td><td rowspan=1 colspan=1>&gt;100000</td><td rowspan=1 colspan=1>&lt;0.3%</td></tr><tr><td rowspan=1 colspan=1>Alpha Methadol</td><td rowspan=1 colspan=1>&gt;100000</td><td rowspan=1 colspan=1>&lt;0.3%</td></tr><tr><td rowspan=1 colspan=1>Disopyramide</td><td rowspan=1 colspan=1>&gt;100000</td><td rowspan=1 colspan=1>&lt; 0.3%</td></tr><tr><td rowspan=1 colspan=1>EMDP</td><td rowspan=1 colspan=1>&gt;100000</td><td rowspan=1 colspan=1>&lt;0.3%</td></tr></table>

<table><tr><td colspan="1" rowspan="1">6-AM(Cutoff=10 ng/mL)</td><td colspan="1" rowspan="1">ResultPositive at (ng/ml)</td><td colspan="1" rowspan="1">% Cross-Reactivity</td></tr><tr><td colspan="1" rowspan="1">6-acetylmorphine</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">Acetylcodeine</td><td colspan="1" rowspan="1">&gt;10000</td><td colspan="1" rowspan="1">&lt;0.1%</td></tr><tr><td colspan="1" rowspan="1">Buprenorphine</td><td colspan="1" rowspan="1">&gt;10000</td><td colspan="1" rowspan="1">&lt;0.1%</td></tr><tr><td colspan="1" rowspan="1">Codeine</td><td colspan="1" rowspan="1">&gt;10000</td><td colspan="1" rowspan="1">&lt;0.1%</td></tr><tr><td colspan="1" rowspan="1">Diacetylmorphine</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">0.01%</td></tr><tr><td colspan="1" rowspan="1">Dihydrocodeine</td><td colspan="1" rowspan="1">&gt;10000</td><td colspan="1" rowspan="1">&lt;0.1%</td></tr><tr><td colspan="1" rowspan="1">Ethylmorphine</td><td colspan="1" rowspan="1">&gt;10000</td><td colspan="1" rowspan="1">&lt;0.1%</td></tr><tr><td colspan="1" rowspan="1">Hydrocodone</td><td colspan="1" rowspan="1">&gt;10000</td><td colspan="1" rowspan="1">&lt;0.1%</td></tr><tr><td colspan="1" rowspan="1">Hydromorphone</td><td colspan="1" rowspan="1">5000</td><td colspan="1" rowspan="1">0.002%</td></tr><tr><td colspan="1" rowspan="1">Morphine</td><td colspan="1" rowspan="1">10000</td><td colspan="1" rowspan="1">0.001%</td></tr><tr><td colspan="1" rowspan="1">Morphine-3-glucuronide</td><td colspan="1" rowspan="1">&gt;10000</td><td colspan="1" rowspan="1">&lt;0.1%</td></tr><tr><td colspan="1" rowspan="1">Nalorphine</td><td colspan="1" rowspan="1">5000</td><td colspan="1" rowspan="1">0.002%</td></tr><tr><td colspan="1" rowspan="1">Thebaine</td><td colspan="1" rowspan="1">&gt;20000</td><td colspan="1" rowspan="1">&lt;0.05%</td></tr><tr><td colspan="1" rowspan="1">Dextromethorphan</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">Heroin</td><td colspan="1" rowspan="1">100000</td><td colspan="1" rowspan="1">0.0001%</td></tr><tr><td colspan="1" rowspan="1">Imipramine</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">LAAM (Levacetylmethadol)</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">Levorphanol</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">Meperidine</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">Methadone</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">Mitragynine (kratom)</td><td colspan="1" rowspan="1">&gt;20,000</td><td colspan="1" rowspan="1">&lt;0.05%</td></tr><tr><td colspan="1" rowspan="1">Morphine 6-D-glucuronide</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">Naloxone</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">Naltrexone</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">Naproxen</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">Norbuprenorphine</td><td colspan="1" rowspan="1">&gt;10,000</td><td colspan="1" rowspan="1">&lt;0.1%</td></tr><tr><td colspan="1" rowspan="1">Norbuprenorphineglucuronide</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">Norcodeine</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">Norhydrocodone</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">Normorphine</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">Noroxycodone</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">Noroxymorphone</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">Norpropoxyphene</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">Oxycodone</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">Oxymorphone</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">Oxymorphone-3β-D-glucuronide</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">Tapentadol HCl</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr><tr><td colspan="1" rowspan="1">Tramadol</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;0.01%</td></tr></table>

# Interfering substances:

Potential interfering substances found in human urine of physiological or pathological conditions were added to drug-free urine and urine samples with concentrations of the target drugs at $2 5 \%$ below and $2 5 \%$ above cutoff levels. These urine samples were tested using three lots of each device. The compounds were tested at $1 0 0 ~ \mathrm { u g / m L }$ (unless otherwise noted in the table). No interference was observed for any of the compounds tested, and the list of compounds is provided in the following table.

<table><tr><td colspan="1" rowspan="1">Acetaminophen</td><td colspan="1" rowspan="1">Creatinine</td><td colspan="1" rowspan="1">Ketamine</td><td colspan="1" rowspan="1">Prednisone</td></tr><tr><td colspan="1" rowspan="1">Acetophenetidin</td><td colspan="1" rowspan="1">Deoxycorticosterone</td><td colspan="1" rowspan="1">Ketoprofen</td><td colspan="1" rowspan="1">(±)-Propranolol</td></tr><tr><td colspan="1" rowspan="1">N-Acetylprocainamide</td><td colspan="1" rowspan="1">Dextromethorphan</td><td colspan="1" rowspan="1">Labetalol</td><td colspan="1" rowspan="1">Pseudoephedrine</td></tr><tr><td colspan="1" rowspan="1">Acetylsalicylic acid</td><td colspan="1" rowspan="1">Diclofenac</td><td colspan="1" rowspan="1">Loperamide</td><td colspan="1" rowspan="1">Quinine</td></tr><tr><td colspan="1" rowspan="1">Albumin(100mg/dL)</td><td colspan="1" rowspan="1">Diflunisal</td><td colspan="1" rowspan="1">Meperidine</td><td colspan="1" rowspan="1">Ranitidine</td></tr><tr><td colspan="1" rowspan="1">Aminopyrine</td><td colspan="1" rowspan="1">Digoxin</td><td colspan="1" rowspan="1">Meprobamate</td><td colspan="1" rowspan="1">Salicylic acid</td></tr><tr><td colspan="1" rowspan="1">Amoxicillin</td><td colspan="1" rowspan="1">Diphenhydramine</td><td colspan="1" rowspan="1">Methoxyphenamine</td><td colspan="1" rowspan="1">Serotonin (5-Hydroxytyramine)</td></tr><tr><td colspan="1" rowspan="1">Ampicillin</td><td colspan="1" rowspan="1">1% Ethanol</td><td colspan="1" rowspan="1">Nalidixic acid</td><td colspan="1" rowspan="1">Sulfamethazine</td></tr><tr><td colspan="1" rowspan="1">Apomorphine</td><td colspan="1" rowspan="1">Ecgonine methyl ester</td><td colspan="1" rowspan="1">Naloxone</td><td colspan="1" rowspan="1">Sulindac</td></tr><tr><td colspan="1" rowspan="1">Ascorbic acid</td><td colspan="1" rowspan="1">β-Estradiol</td><td colspan="1" rowspan="1">Naltrexone</td><td colspan="1" rowspan="1">Tetrahydrocortisone 3-(β- Dglucuronide)</td></tr><tr><td colspan="1" rowspan="1">Aspartame</td><td colspan="1" rowspan="1">Erythromycin</td><td colspan="1" rowspan="1">Naproxen</td><td colspan="1" rowspan="1">Tetrahydrocortisone 3-acetate</td></tr><tr><td colspan="1" rowspan="1">Atropine</td><td colspan="1" rowspan="1">Fenoprofen</td><td colspan="1" rowspan="1">Niacinamide</td><td colspan="1" rowspan="1">Tetrahydrozoline</td></tr><tr><td colspan="1" rowspan="1">Benzilic acid</td><td colspan="1" rowspan="1">Furosemide</td><td colspan="1" rowspan="1">Nifedipine</td><td colspan="1" rowspan="1">Thiamine</td></tr><tr><td colspan="1" rowspan="1">Benzoic acid</td><td colspan="1" rowspan="1">Gentisic acid</td><td colspan="1" rowspan="1">Norethindrone</td><td colspan="1" rowspan="1">Thioridazine</td></tr><tr><td colspan="1" rowspan="1">Bilirubin (500μg/mL)</td><td colspan="1" rowspan="1">Hemoglobin</td><td colspan="1" rowspan="1">Noscapine</td><td colspan="1" rowspan="1">Triamterene</td></tr><tr><td colspan="1" rowspan="1">Chloral hydrate</td><td colspan="1" rowspan="1">Hydralazine</td><td colspan="1" rowspan="1">(±)-Octopamine</td><td colspan="1" rowspan="1">Trifluoperazine</td></tr><tr><td colspan="1" rowspan="1">Chloramphenicol</td><td colspan="1" rowspan="1">Hydrochlorothiazide</td><td colspan="1" rowspan="1">Oxalic acid</td><td colspan="1" rowspan="1">Trimethoprim</td></tr><tr><td colspan="1" rowspan="1">Chlorothiazide</td><td colspan="1" rowspan="1">Hydrocortisone</td><td colspan="1" rowspan="1">Oxolinic acid</td><td colspan="1" rowspan="1">DL-Tryptophan</td></tr><tr><td colspan="1" rowspan="1">Chlorpromazine</td><td colspan="1" rowspan="1">O-Hydroxyhippuricacid</td><td colspan="1" rowspan="1">Oxymetazoline</td><td colspan="1" rowspan="1">Tyramine</td></tr><tr><td colspan="1" rowspan="1">Cholesterol</td><td colspan="1" rowspan="1">3-Hydroxytyramine</td><td colspan="1" rowspan="1">Papaverine</td><td colspan="1" rowspan="1">DL-Tyrosine</td></tr><tr><td colspan="1" rowspan="1">Clonidine</td><td colspan="1" rowspan="1">Ibuprofen</td><td colspan="1" rowspan="1">Penicillin G</td><td colspan="1" rowspan="1">Uric acid</td></tr><tr><td colspan="1" rowspan="1">Cortisone</td><td colspan="1" rowspan="1">Isoproterenol</td><td colspan="1" rowspan="1">Perphenazine</td><td colspan="1" rowspan="1">Verapamil</td></tr><tr><td colspan="1" rowspan="1">(-)-Cotinine</td><td colspan="1" rowspan="1">Isoxsuprine</td><td colspan="1" rowspan="1">Phenelzine</td><td colspan="1" rowspan="1">Zomepirac</td></tr></table>

# Effect of Urinary Specific Gravity and pH:

To investigate the effect of urine specific gravity and urine $\mathsf { p H }$ , urine samples, with specific gravity ranging from 1.000 to 1.035 or urine samples with $\mathsf { p H }$ ranging from 4 to 9 were spiked with the target drugs to concentrations at $2 5 \%$ below and $2 5 \%$ above cutoff levels. These samples were tested using three lots of each device. Results were all positive for samples at $+ 2 5 \%$ cutoff and all negative for samples at $- 2 5 \%$ cutoff.

4. Assay Reportable Range: Not applicable.

5. Traceability, Stability, Expected Values (Controls, Calibrators, or Methods): The device is traceable to commercially available reference materials.

6. Detection Limit: Not applicable.

Refer to Section VII.A.1

# B Comparison Studies:

1. Method Comparison with Predicate Device:

Method comparison studies for the BIOEASY U-Catch MAX Multi-Drug Test Cup Rx were performed by three operators. Eighty (80) unaltered clinical samples were run for each target drug. The samples were tested in a blinded fashion and compared to LC/MS results. The results are presented in the tables below for Amphetamine 500, Cocaine 150, Methamphetamine 500, 2-ethylidene-1, 5-dimethyl-3, 3-diphenylpyrrolidine (EDDP), and 6- acetylmorphine (6-AM). The data for Buprenorphine, Methylenedioxymethamphetamine, Secobarbital, Oxazepam, Morphine, Methadone, Oxycodone, Phencyclidine, dPropoxyphene, Nortriptyline and Cannabinoids were previously reported in K182530.

AMP 500:   

<table><tr><td rowspan=1 colspan=1>BIOEASY U-Catch MAXMulti- Drug TestCup Rx</td><td rowspan=1 colspan=1>−</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Low Negativeby LC/MS(less than -50%</td><td rowspan=1 colspan=1>Near CutoffNegative byLC/MS(Between -50%and cutoff)</td><td rowspan=1 colspan=1>Near CutoffPositive byLC/MS(Between cutoffand +50%)</td><td rowspan=1 colspan=1>High Positiveby LC/MS(greater than+50%</td></tr><tr><td rowspan=2 colspan=1>Viewer A</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer B</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer C</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant Results   

<table><tr><td colspan="1" rowspan="1">Viewer</td><td colspan="1" rowspan="1">Sample Number</td><td colspan="1" rowspan="1">LC/MSResult</td><td colspan="1" rowspan="1">Dip CardViewerResults</td></tr><tr><td colspan="1" rowspan="1">Viewer A</td><td colspan="1" rowspan="1">AMPLC063</td><td colspan="1" rowspan="1">473</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Viewer C</td><td colspan="1" rowspan="1">AMPLC063</td><td colspan="1" rowspan="1">473</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Viewer B</td><td colspan="1" rowspan="1">AMPLC040</td><td colspan="1" rowspan="1">477</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Viewer A</td><td colspan="1" rowspan="1">AMPLC039</td><td colspan="1" rowspan="1">490</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Viewer B</td><td colspan="1" rowspan="1">AMPLC039</td><td colspan="1" rowspan="1">490</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Viewer C</td><td colspan="1" rowspan="1">AMPLC039</td><td colspan="1" rowspan="1">490</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Viewer A</td><td colspan="1" rowspan="1">AMPLC004</td><td colspan="1" rowspan="1">494</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Viewer C</td><td colspan="1" rowspan="1">AMPLC004</td><td colspan="1" rowspan="1">494</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Viewer A</td><td colspan="1" rowspan="1">AMPLC018</td><td colspan="1" rowspan="1">520</td><td colspan="1" rowspan="1">Negative</td></tr><tr><td colspan="1" rowspan="1">Viewer B</td><td colspan="1" rowspan="1">AMPLC018</td><td colspan="1" rowspan="1">520</td><td colspan="1" rowspan="1">Negative</td></tr><tr><td colspan="1" rowspan="1">Viewer A</td><td colspan="1" rowspan="1">AMPLC064</td><td colspan="1" rowspan="1">525</td><td colspan="1" rowspan="1">Negative</td></tr><tr><td colspan="1" rowspan="1">Viewer B</td><td colspan="1" rowspan="1">AMPLC064</td><td colspan="1" rowspan="1">525</td><td colspan="1" rowspan="1">Negative</td></tr><tr><td colspan="1" rowspan="1">Viewer C</td><td colspan="1" rowspan="1">AMPLC064</td><td colspan="1" rowspan="1">525</td><td colspan="1" rowspan="1">Negative</td></tr><tr><td colspan="1" rowspan="1">Viewer A</td><td colspan="1" rowspan="1">AMPLC009</td><td colspan="1" rowspan="1">540</td><td colspan="1" rowspan="1">Negative</td></tr><tr><td colspan="1" rowspan="1">Viewer C</td><td colspan="1" rowspan="1">AMPLC014</td><td colspan="1" rowspan="1">570</td><td colspan="1" rowspan="1">Negative</td></tr></table>

COC 150   

<table><tr><td rowspan=1 colspan=1>BIOEASY U-Catch MAXMulti- Drug TestCup Rx</td><td rowspan=1 colspan=1>−</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Low Negativeby LC/MS(less than -50%</td><td rowspan=1 colspan=1>Near CutoffNegative byLCMS(Between -50%and cutoff)</td><td rowspan=1 colspan=1>Near CutoffPositive byLC/MS(Between cutoffand +50%)</td><td rowspan=1 colspan=1>High Positiveby LC/MS(greater than+50%)</td></tr><tr><td rowspan=2 colspan=1>Viewer A</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>19</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer B</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>19</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer C</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>19</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant Results   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>LC/MSResult</td><td rowspan=1 colspan=1>Dip CardViewerResults</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>COCLC046</td><td rowspan=1 colspan=1>139</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>COCLC019</td><td rowspan=1 colspan=1>142</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>COCLC019</td><td rowspan=1 colspan=1>142</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>COCLC026</td><td rowspan=1 colspan=1>142</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>COCLC060</td><td rowspan=1 colspan=1>145</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>COCLC060</td><td rowspan=1 colspan=1>145</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>COCLC049</td><td rowspan=1 colspan=1>154</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>COCLC049</td><td rowspan=1 colspan=1>154</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>COCLC049</td><td rowspan=1 colspan=1>154</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>COCLC024</td><td rowspan=1 colspan=1>157</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>COCLC062</td><td rowspan=1 colspan=1>157</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>COCLC062</td><td rowspan=1 colspan=1>157</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>COCLC029</td><td rowspan=1 colspan=1>159</td><td rowspan=1 colspan=1>Negative</td></tr></table>

<table><tr><td rowspan=1 colspan=1>BIOEASY U-Catch MAXMulti- Drug TestCup Rx</td><td rowspan=1 colspan=1>−</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Low Negativeby LC/MS(less than -50%</td><td rowspan=1 colspan=1>Near CutoffNegative byLCMS(Between -50%and cutoff)</td><td rowspan=1 colspan=1>Near CutoffPositive byLC/MS(Between cutoffand +50%)</td><td rowspan=1 colspan=1>High Positiveby LC/MS(greater than+50%)</td></tr><tr><td rowspan=2 colspan=1>Viewer A</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer B</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer C</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant Results   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>LC/MSResult</td><td rowspan=1 colspan=1>Dip CardViewerResults</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>METL055</td><td rowspan=1 colspan=1>427</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>METL005</td><td rowspan=1 colspan=1>447</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>METL005</td><td rowspan=1 colspan=1>447</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>METL020</td><td rowspan=1 colspan=1>465</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>METL020</td><td rowspan=1 colspan=1>465</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>METL063</td><td rowspan=1 colspan=1>486</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>METL063</td><td rowspan=1 colspan=1>486</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>METL053</td><td rowspan=1 colspan=1>525</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>METL053</td><td rowspan=1 colspan=1>525</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>METL060</td><td rowspan=1 colspan=1>530</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>METL060</td><td rowspan=1 colspan=1>530</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>METL036</td><td rowspan=1 colspan=1>540</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>METL036</td><td rowspan=1 colspan=1>540</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>METL059</td><td rowspan=1 colspan=1>555</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>METL059</td><td rowspan=1 colspan=1>555</td><td rowspan=1 colspan=1>Negative</td></tr></table>

EDDP   

<table><tr><td colspan="1" rowspan="1">BIOEASY U-Catch MAXMulti- Drug TestCup Rx</td><td colspan="1" rowspan="1">−</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Low Negativeby LC/MS(less than -50%)</td><td colspan="1" rowspan="1">Near CutoffNegative byLC/MS(Between -50%and cutoff)</td><td colspan="1" rowspan="1">Near CutoffPositive byLC/MS(Between cutoffand +50%)</td><td colspan="1" rowspan="1">High Positiveby LC/MS(greater than+50%</td></tr><tr><td colspan="1" rowspan="2">Viewer A</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">18</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">6</td><td colspan="1" rowspan="1">18</td><td colspan="1" rowspan="1">14</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="2">Viewer B</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">18</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">6</td><td colspan="1" rowspan="1">18</td><td colspan="1" rowspan="1">14</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="2">Viewer C</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1">18</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">6</td><td colspan="1" rowspan="1">18</td><td colspan="1" rowspan="1">13</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">0</td></tr></table>

Discordant Results   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>LC/MSResult</td><td rowspan=1 colspan=1>Dip CardViewerResults</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>EDDPLC042</td><td rowspan=1 colspan=1>244</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>EDDPLC042</td><td rowspan=1 colspan=1>244</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>EDDPLC004</td><td rowspan=1 colspan=1>291</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>EDDPLC004</td><td rowspan=1 colspan=1>291</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>EDDPLC051</td><td rowspan=1 colspan=1>294</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>EDDPLC051</td><td rowspan=1 colspan=1>294</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>EDDPLC051</td><td rowspan=1 colspan=1>294</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>EDDPLC074</td><td rowspan=1 colspan=1>303</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>EDDPLC074</td><td rowspan=1 colspan=1>303</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>EDDPLC074</td><td rowspan=1 colspan=1>303</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>EDDPLC052</td><td rowspan=1 colspan=1>327</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>EDDPLC018</td><td rowspan=1 colspan=1>330</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>EDDPLC018</td><td rowspan=1 colspan=1>330</td><td rowspan=1 colspan=1>Negative</td></tr></table>

6-AM   

<table><tr><td rowspan=1 colspan=1>BIOEASY U-Catch MAXMulti- Drug TestCup Rx</td><td rowspan=1 colspan=1>−</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Low Negativeby LC/MS(less than -50%)</td><td rowspan=1 colspan=1>Near CutoffNegative byLC/MS(Between -50%and cutoff)</td><td rowspan=1 colspan=1>Near CutoffPositive byLC/MS(Between cutoffand +50%)</td><td rowspan=1 colspan=1>High Positiveby LC/MS(greater than+50%</td></tr><tr><td rowspan=2 colspan=1>Viewer A</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>22</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer B</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>22</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer C</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>22</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant Results   

<table><tr><td colspan="1" rowspan="1">Viewer</td><td colspan="1" rowspan="1">Sample Number</td><td colspan="1" rowspan="1">LC/MSResult</td><td colspan="1" rowspan="1">Dip CardViewerResults</td></tr><tr><td colspan="1" rowspan="1">Viewer B</td><td colspan="1" rowspan="1">6-AMLC016</td><td colspan="1" rowspan="1">9.23</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Viewer A</td><td colspan="1" rowspan="1">6-AMLC074</td><td colspan="1" rowspan="1">9.68</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Viewer C</td><td colspan="1" rowspan="1">6-AMLC074</td><td colspan="1" rowspan="1">9.68</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Viewer B</td><td colspan="1" rowspan="1">6-AMLC026</td><td colspan="1" rowspan="1">9.93</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Viewer A</td><td colspan="1" rowspan="1">6-AMLC037</td><td colspan="1" rowspan="1">9.95</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Viewer C</td><td colspan="1" rowspan="1">6-AMLC037</td><td colspan="1" rowspan="1">9.95</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Viewer A</td><td colspan="1" rowspan="1">6-AMLC009</td><td colspan="1" rowspan="1">10.3</td><td colspan="1" rowspan="1">Negative</td></tr><tr><td colspan="1" rowspan="1">Viewer C</td><td colspan="1" rowspan="1">6-AMLC009</td><td colspan="1" rowspan="1">10.3</td><td colspan="1" rowspan="1">Negative</td></tr><tr><td colspan="1" rowspan="1">Viewer B</td><td colspan="1" rowspan="1">6-AMLC027</td><td colspan="1" rowspan="1">11.1</td><td colspan="1" rowspan="1">Negative</td></tr><tr><td colspan="1" rowspan="1">Viewer C</td><td colspan="1" rowspan="1">6-AMLC027</td><td colspan="1" rowspan="1">11.1</td><td colspan="1" rowspan="1">Negative</td></tr><tr><td colspan="1" rowspan="1">Viewer A</td><td colspan="1" rowspan="1">6-AMLC038</td><td colspan="1" rowspan="1">11.4</td><td colspan="1" rowspan="1">Negative</td></tr><tr><td colspan="1" rowspan="1">Viewer B</td><td colspan="1" rowspan="1">6-AMLC038</td><td colspan="1" rowspan="1">11.4</td><td colspan="1" rowspan="1">Negative</td></tr><tr><td colspan="1" rowspan="1">Viewer C</td><td colspan="1" rowspan="1">6-AMLC035</td><td colspan="1" rowspan="1">11.8</td><td colspan="1" rowspan="1">Negative</td></tr></table>

Lay user study

A lay user study was performed using the BIOEASY U-Catch MAX Multi-Drug Test Cup at three intended use sites with 140 lay persons. The lay users had diverse ages and educational and professional backgrounds. Urine samples were prepared at multiple concentrations (Negative $( - 1 0 0 \% )$ , $+ / - 7 5 \%$ , $+ / - 5 0 \%$ , $+ / - 2 5 \%$ of the cutoff) by spiking drugs into drug free pooled urine specimens. The concentrations of the samples were confirmed by LC/MS. Each sample was aliquoted into individual containers and tested in a blinded fashion. Each participant was provided with the package insert, one blind-labeled sample and a device, and no additional training. Summary results are shown below:

<table><tr><td colspan="1" rowspan="2">Drugs</td><td colspan="1" rowspan="2">% of Cutoff</td><td colspan="1" rowspan="2">Number ofsamples</td><td colspan="2" rowspan="1">Lay person results</td><td colspan="1" rowspan="2">Thepercentage ofcorrectresults(%)</td></tr><tr><td colspan="1" rowspan="1">No. ofPositive</td><td colspan="1" rowspan="1">No. ofNegative</td></tr><tr><td colspan="1" rowspan="7">AMP</td><td colspan="1" rowspan="1">-100% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-75% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-50% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-25% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">+25% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">95</td></tr><tr><td colspan="1" rowspan="1">+50% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">+75% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="6">BAR</td><td colspan="1" rowspan="1">-100% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-75% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-50% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-25% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">+25% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">95</td></tr><tr><td colspan="1" rowspan="1">+50% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="3">Drugs</td><td colspan="1" rowspan="2">% of Cutoff</td><td colspan="1" rowspan="2">Number ofsamples</td><td colspan="2" rowspan="1">Lay person results</td><td colspan="1" rowspan="2">Thepercentage ofcorrectresults(%)</td></tr><tr><td colspan="1" rowspan="1">No. ofPositive</td><td colspan="1" rowspan="1">No. ofNegative</td></tr><tr><td colspan="1" rowspan="1">+75% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="7">COC</td><td colspan="1" rowspan="1">-100% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-75% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-50% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-25% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">95</td></tr><tr><td colspan="1" rowspan="1">+25% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">95</td></tr><tr><td colspan="1" rowspan="1">+50% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">+75% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="7">BZO</td><td colspan="1" rowspan="1">-100% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-75% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-50% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-25% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">95</td></tr><tr><td colspan="1" rowspan="1">+25% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">95</td></tr><tr><td colspan="1" rowspan="1">+50% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">+75% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="7">MET</td><td colspan="1" rowspan="1">-100% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-75% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-50% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-25% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">+25% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">95</td></tr><tr><td colspan="1" rowspan="1">+50% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">+75% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="7">MTD</td><td colspan="1" rowspan="1">-100% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-75% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-50% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-25% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">+25% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">95</td></tr><tr><td colspan="1" rowspan="1">+50% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">+75% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="7">MOP</td><td colspan="1" rowspan="1">-100% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-75% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-50% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-25% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">95</td></tr><tr><td colspan="1" rowspan="1">+25% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">95</td></tr><tr><td colspan="1" rowspan="1">+50% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">+75% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="4"></td><td colspan="1" rowspan="1">-100% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-75% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-50% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-25% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="5">DrugsOXY</td><td colspan="1" rowspan="2">% of Cutoff</td><td colspan="1" rowspan="2">Number ofsamples</td><td colspan="2" rowspan="1">Lay person results</td><td colspan="1" rowspan="2">Thepercentage ofcorrectresults(%)</td></tr><tr><td colspan="1" rowspan="1">No. ofPositive</td><td colspan="1" rowspan="1">No. ofNegative</td></tr><tr><td colspan="1" rowspan="1">+25% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">95</td></tr><tr><td colspan="1" rowspan="1">+50% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">+75% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="7">THC</td><td colspan="1" rowspan="1">-100% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-75% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-50% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-25% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">95</td></tr><tr><td colspan="1" rowspan="1">+25% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">95</td></tr><tr><td colspan="1" rowspan="1">+50% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">+75% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="7">TCA</td><td colspan="1" rowspan="1">-100% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-75% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-50% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-25% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">+25% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">95</td></tr><tr><td colspan="1" rowspan="1">+50% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">+75% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="7">BUP</td><td colspan="1" rowspan="1">-100% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-75% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-50% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-25% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">95</td></tr><tr><td colspan="1" rowspan="1">+25% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">95</td></tr><tr><td colspan="1" rowspan="1">+50% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">+75% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="7">PCP</td><td colspan="1" rowspan="1">-100% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-75% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-50% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-25% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">95</td></tr><tr><td colspan="1" rowspan="1">+25% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">95</td></tr><tr><td colspan="1" rowspan="1">+50% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">+75% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="7">MDMA</td><td colspan="1" rowspan="1">-100% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-75% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-50% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-25% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">+25% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">95</td></tr><tr><td colspan="1" rowspan="1">+50% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">+75% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="2"></td><td colspan="1" rowspan="1">-100% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-75% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="7">DrugsEDDP</td><td colspan="1" rowspan="2">% of Cutoff</td><td colspan="1" rowspan="2">Number ofsamples</td><td colspan="2" rowspan="1">Lay person results</td><td colspan="1" rowspan="2">Thepercentage ofcorrectresults(%)</td></tr><tr><td colspan="1" rowspan="1">No. ofPositive</td><td colspan="1" rowspan="1">No. ofNegative</td></tr><tr><td colspan="1" rowspan="1">-50% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-25% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">95</td></tr><tr><td colspan="1" rowspan="1">+25% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">+50% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">+75% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="7">PPX</td><td colspan="1" rowspan="1">-100% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-75% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-50% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-25% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">95</td></tr><tr><td colspan="1" rowspan="1">+25% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">+50% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">+75% cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr></table>

2. Matrix Comparison: Not Applicable.

# C Clinical Studies:

1. Clinical Sensitivity: Not Applicable.

2. Clinical Specificity: Not Applicable.

3. Other Clinical Supportive Data (When 1. and 2. Are Not Applicable):

Read Time: The sponsor provided data to support the recommendation for read time. The sponsor recommends that the results should be read 5-30 minutes after testing.

# D Clinical Cutoff:

Not Applicable.

# E Expected Values/Reference Range:

Not Applicable.

The labeling support the finding of substantial equivalence for this device.

# IX Conclusion:

The submitted information in this premarket notification is complete and supports a substantial equivalence decision.